0016-3813
0016-3813
S0016-38132025000600669
10.24875/gmm.25000194
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
México
00
12
2025
00
12
2025
161
6
669
684
[
2023
28
294
]
[
2024
39
196-208
]
[
2018
90
777-88
]
[
2018
24
96-120
]
[
2017
16
658-65
]
[
2022
36
1285-99
]
[
2024
271
3116-30
]
[
2024
271
105-15
]
[
2024
]
[
2023
77
47-60
]
[
2021
14
17562864211039648
]
[
2022
269
2806-18
]
[
2020
133
1380-90.e2
]
[
2023
77
104840
]
[
2020
37
(Suppl 1)
(Suppl 1)
S43-9
]
[
2020
26
1352458520924595
]
[
2024
91
105881
]
[
2021
50
104068
]
[
2017
23
704-10
]
[
2017
23
711-20
]
[
2017
23
721-33
]
[
2012
18
1074-80
]
[
2019
12
1-17
]
[
2022
65
103995
]
[
2024
81
105134
]
[
2018
25
1270-5
]
[
2023
37
915-27
]
[
2024
37
220-7
]
[
2023
22
568-77
]
[
2024
23
12-6
]
[
2021
16
806-17
]
[
NICE guideline
]
[
2015
18
(Suppl 1)
(Suppl 1)
S35-42
]
[
2020
27
1510-29
]
[
2022
13
824926
]
[
The Multiple Sclerosis International Federation
3rd
]
[
2018
379
1017-27
]
[
2021
20
1001-11
]
[
2022
5
]
[
2010
16
1258-67
]
[
2023
43
1-5
]
[
2014
83
142-50
]
[
2024
31
]
[
2022
61
103421
]
[
2021
78
1197-204
]
[
2023
79
104942
]
[
2024
14
]
[
2011
118
790-7
]
[
2020
77
327-38
]
[
2023
29
395-406
]
[
2024
30
899-924
]
[
2020
10
2954
]
[
2024
15
1379538
]
[
2024
271
3794-805
]
[
2024
271
711-22
]
[
2023
14
1197212
]
[
2024
30
847-56
]
[
2024
13
519-33
]
[
2020
11
851
]
[
2023
22
103312
]
[
2021
53
103053
]
[
2021
20
653-70
]
[
2022
59
103649
]
[
2018
25
1107-e101
]
[
2019
25
1809-18
]
[
2023
18
39-50
]
[
2021
42
5183-93
]
[
2023
13
2077
]
[
2023
44
667-76
]
[
2024
184
105376
]
[
2024
15
1407257
]
[
2024
101
104970
]
[
2021
144
2954-63
]
[
2019
31
173-88
]
[
2021
14
17562864211019598
]
[
2023
30
2144-76
]